> Dear Allstaters,
>
> please find attached the latest permanent vacancy for you to review;
>
> TITLE: Trial Statistician - CVM Specialist
>
> DESCRIPTION: Essntial; educated to M.Sc in Statistics / Bostatistics /
> related subject, minimum of 4 years pharmaceutical development / clinical
> research, familiar with analysis / reporting of clinical trials,
> experience in supporting clinical publications & strong SAS programming
> skills. Desirable; any experience of dealing with CROs. Acting as Trial
> Statistician for this major pharmaceutical your duties will include;
> analyses to support publication in the CVM area, monitor CRO in analysis &
> reporting of a Phase IIIb outcome study.
>
> CONTRACT LENGTH: 6 months+
> START DATE: ASAP, but they will wait for notice periods
> LOCATION: Switzerland
> SALARY: Dependant on experience
>
> If you are interested in this role please get in contact ASAP for a
> confidential chat and more details.
>
> Regards
>
> James Carrera
> European Contracts Manager
> Pharmaceutical, Healthcare & CRO division.
> 1st IT People
> Tel: +44 (0) 207 940 3900
> Fax: +44 (0) 207 886 8161
> mailto:[log in to unmask]
> www.1st-itpeople.com
>
> Offices in UK, Switzerland, The Netherlands & Hong Kong
> This email is confidential and intended solely for the use of the
> individual to whom it is addressed. Any views or opinions presented are
> solely those of the author and do not represent those of the company from
> which the email was sent. If you are not the intended recipient, be
> advised that you have received this e-mail in error and that any use,
> dissemination forwarding, printing or copying of this e-mail is strictly
> prohibited. While every effort has been made to scan this e-mail, we can
> not accept any responsibility for loss of business or damage caused
> arising from this e-mail.
>
This email is confidential and intended solely for the use of the
individual to whom it is addressed. Any views or opinions presented are
solely those of the author and do not represent those of the company from
which the email was sent. If you are not the intended recipient, be advised
that you have received this e-mail in error and that any use, dissemination
forwarding, printing or copying of this e-mail is strictly prohibited.
While every effort has been made to scan this e-mail, we can not accept any
responsibility for loss of business or damage caused arising from this
e-mail.
|